KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Equity Ratio (2018 - 2025)

Adaptive Biotechnologies' Equity Ratio history spans 8 years, with the latest figure at 0.44 for Q4 2025.

  • For Q4 2025, Equity Ratio rose 16.89% year-over-year to 0.44; the TTM value through Dec 2025 reached 0.44, up 16.89%, while the annual FY2025 figure was 0.44, 16.89% up from the prior year.
  • Equity Ratio for Q4 2025 was 0.44 at Adaptive Biotechnologies, up from 0.42 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.68 in Q1 2021 and bottomed at 0.36 in Q2 2025.
  • The 5-year median for Equity Ratio is 0.51 (2023), against an average of 0.51.
  • The largest annual shift saw Equity Ratio fell 20.56% in 2024 before it grew 16.89% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.65 in 2021, then fell by 17.19% to 0.54 in 2022, then decreased by 13.93% to 0.47 in 2023, then dropped by 19.49% to 0.38 in 2024, then rose by 16.89% to 0.44 in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Equity Ratio are 0.44 (Q4 2025), 0.42 (Q3 2025), and 0.36 (Q2 2025).